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Abstract
We discuss to what extent disease transmission models provide reliable predictions. The concept of prediction is delineated as it is
understood by modellers, and illustrated by some classic and recent examples. A precondition for a model to provide valid predictions is
that the assumptions underlying it correspond to the reality, but such correspondence is always limited—all models are simpliﬁcations of
reality. A central tenet of the modelling enterprise is what we may call the ‘robustness thesis’: a model whose assumptions approximately
correspond to reality will make predictions that are approximately valid. To examine which of the predictions made by a model are
trustworthy, it is essential to examine the outcomes of different models. Thus, if a highly simpliﬁed model makes a prediction, and if the
same or a very similar prediction is made by a more elaborate model that includes some mechanisms or details that the ﬁrst model did not,
then we gain some conﬁdence that the prediction is robust. An important beneﬁt derived from mathematical modelling activity is that it
demands transparency and accuracy regarding our assumptions, thus enabling us to test our understanding of the disease epidemiology by
comparing model results and observed patterns. Models can also assist in decision-making by making projections regarding important issues
such as intervention-induced changes in the spread of disease.
Keywords: Epidemic modelling, HPV, model prediction, pandemic inﬂuenza, reproductive number, SIR
Article published online: 25 June 2013
Clin Microbiol Infect 2013; 19: 999–1005
Corresponding author: A. Huppert, The Gertner Institute, Chaim
Sheba Medical Centre, Tel Hashomer, 52621 Israel
E-mail: amit.huppert@gmail.com
*Contributed equally to the article.
Introduction
Can mathematical models in the ﬁeld of infectious diseases
provide predictions? We argue that they can and do, provided
that the scope of the notion of prediction is suitably qualiﬁed.
Below, we will delineate the concept of prediction as we
believe it is understood by mathematical modellers, illustrating
it by some classic and recent examples.
A mathematical model is an imaginary microworld consist-
ing of entities behaving according to precisely speciﬁed rules.
Mathematics provides us with a language for formulating these
rules of behaviour in a concise and unambiguous way, thus
forcing and helping us to clearly state our assumptions. Once a
mathematical model is constructed, mathematical analysis,
often combined with computer simulations, helps us to
investigate the global behaviour of the model, drawing out
the consequences of the assumptions that we have made.
Thus, within the context of the model, we can make
predictions of the future of our imaginary world and also
study how these predictions change as the rules governing the
entities described by the model are varied.
Thus, a mathematical model for the spread of an infectious
disease in a population of hosts describes the transmission of
the pathogen among hosts, depending on patterns of contacts
among infectious and susceptible individuals, the latency period
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from being infected to becoming infectious, the duration of
infectiousness, the extent of immunity acquired following
infection, and so on. Once all of these factors are formulated in
a model, we can make predictions about the number of
individuals who are expected to be infected during an
epidemic, the duration of the epidemic, the peak incidence,
and, indeed, we can predict the entire epidemic curve,
providing us with the expected number of cases at each point
in time.
Clearly, for the precise predictions made within the model’s
virtual world to be relevant to reality, the model itself needs to
correspond to or represent what is occurring in the real world
—one cannot expect to obtain good predictions from false
assumptions. However, modellers are well aware of the fact
that all models are, at best, partial descriptions of the
mechanisms operating in reality, containing various layers of
simpliﬁcation, idealization, approximation, and abstraction.
Indeed, much of the discussion and debate among modellers
involves the nature of these simpliﬁcations and their appro-
priateness. Thus, a central tenet of the modelling enterprise is
what we may call the ‘robustness thesis’: a model whose
assumptions approximately correspond to reality will make
predictions that are approximately valid. If one accepts this
general (and admittedly vague) idea, then even highly simpliﬁed
models—which clearly overlook or even contradict some
aspects of reality—can provide some valuable predictions, as
long as their assumptions mirror some central aspects of
reality. Deciding which of the predictions of a simple model are
robust, in the sense that they can be applied with conﬁdence
to reality, can be a difﬁcult question. An important procedure
that modellers use to test the robustness of predictions made
by a mathematical model is to compare different models [1–3].
Thus, if a highly simpliﬁed model makes a prediction, and if the
same or a very similar prediction is made by a somewhat more
elaborate model that includes some mechanisms or details that
the ﬁrst model did not, then we gain some conﬁdence that the
prediction is robust. If, on the other hand, a certain prediction
is highly dependent on the details of a particular model, then,
as we never expect the model to be more than an approximate
description of reality, we cannot have much faith in that
particular prediction.
The SIR model
Let us illustrate some of the above considerations by reference
to the most famous and paradigmatic model in mathematical
epidemiology, the simple SIR model of Kermack and McKen-
drik [4]. In this model, a population is divided into susceptible,
infective and recovered individuals, with the functions S(t), I(t)
and R(t) denoting their respective fractions in the populations
at time t (measured, for example, in days). The evolution of










where the derivatives dS/dt, dI/dt and dR/dt measure the rates
of change of the quantities S(t), I(t), and R(t). The transmission
parameter b is the average number of individuals that one
infected individual will infect per time unit, assuming that all
contacts that this individual makes are with susceptible
individuals. Thus, a more highly infectious disease has a higher
b. The number c is the rate of recovery, so that 1/c is the
average time period during which an infected individual
remains infectious. The product bS(t) I(t) is the total infection
rate, the fraction of the population that will be infected per
unit time at time t. To understand this, note that, if a fraction I
(t) of the population is currently infected, then they would
infect a fraction bI(t) of the population per unit time if all of
their contacts were with susceptible individuals, but as only a
fraction S(t) of the population is currently susceptible, they will
only infect bI(t) S(t) per unit time.
The ratio b/c is also known as the basic reproductive
number R0, which is an important index for quantifying the
transmission of pathogens. R0 is deﬁned as the average number
of people infected by an infected individual over the disease
infectivity period, in a totally susceptible population.
This simple model, which is the basis for many elaborations,
turns out to provide some quite striking predictions. By
entering the above differential equations into any software for
the numerical solution of differential equations, and choosing
some values for b and c together with the initial values S(0), I
(0), and R(0), it is possible to generate an epidemic curve
corresponding to this model, that is a prediction for the
fraction of the population that will be infected on each day of
the epidemic. Moreover, analytical tools allow us to draw
some general conclusions about the model’s solutions. The
most important conclusions are as follows:
1. The epidemic threshold: if the inequality S(0) R0 > 1 holds,
then the number of infected individuals will rapidly decrease;
that is, no epidemic will occur. Note that, if S(0) R0 > 1,
then an epidemic will occur, no matter how small the initial
number of infected individuals.
2. The size of the epidemic, when it occurs, will not depend
on the initial number of infectives, but it will depend on
the initial fraction of susceptibles, S(0), and on R0. An
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important point here is that the ﬁnal size of the epidemic
(the fraction of the population infected) will always be
strictly smaller than the initial fraction of the population
that was susceptible, S(0), so that there will always remain
a subpopulation of susceptible individuals who have not
been infected.
These conclusions, in so far as they apply in reality, have
some crucial implications. Most notably, the epidemic thresh-
old implies that, if we vaccinate a fraction of the population
prior to the arrival of the pathogen, so as to reduce the initial
fraction of susceptibles to S(0) < c/b, then we will have
prevented an epidemic. This result underlies the concept of
herd immunity, whereby prevention of an epidemic can be
achieved if a sufﬁciently large fraction of the population is
vaccinated. If we do not achieve sufﬁciently high vaccination
coverage, then we will have only reduced the size of the
epidemic, and not have prevented it. Other ways to achieve
the condition S(0) < c/b, and thus to eliminate an epidemic
are: (i) reducing the transmissibility parameter b by isolation of
infectives or social distancing measures; and (ii) increasing the
recovery rate c by treatment of infectives.
Should the predictions from this very simple model be
trusted in policy-making?
Let us ﬁrst note some reasons for scepticism. There are
many assumptions implicit in the SIR models that are not
realistic, for example:
 Well-mixed population—the derivation of the term bS(t) I
(t) in the equations assumes that each individual is equally
likely to come into contact with any other individual in the
population. This ignores the fact that contacts are much
more likely between individuals who are geographically and
socially closer.
 Homogeneity of the population—the model does not allow
for the fact that individuals may be different from each other
in ways that are relevant to the transmission of infection.
There are individuals who are more susceptible to infection
or more infectious than others; and there are individuals
who make more contacts than others.
 Exponentially distributed duration of infection—this refers
to the fact that the model assumes both that a person
becomes infectious immediately upon being infected, and
that the probability of recovery per unit time does not
depend on the time that has passed since infection. Both
assumptions are unrealistic [5].
 Large population—the very form of the model, formulated
in terms of continuous quantities (fractions of the popula-
tion), implicitly assumes that the population is large (strictly
speaking, inﬁnite). In a small population (e.g. a village or
school), stochastic effects are much more important, and
modelling using mean ﬁeld approximations (i.e. by differen-
tial equations) becomes problematic [6].
Given all these unrealistic assumptions, which, if any, of the
predictions made by the model can we take seriously? As we
have indicated above, the main approach with which modellers
can address this question is by constructing more elaborate
models that replace some of the unrealistic assumptions with
more representative ones. Those predictions that remain
unchanged, or only slightly changed, even for the more realistic
model, are deemed to be robust, and we gain some conﬁdence
that they can be applied to the real world. A large part of the
literature on the mathematical modelling of infectious disease
transmission consists precisely of relaxing the above assump-
tions, and some others, by constructing appropriate models,
and examining how the models’ behavior changes as the model
assumptions are modiﬁed [6–8].
Going back to the predictions made by the simple SIR
model above, we can note that the threshold property (i.e.
when S(0)R0 > 1, an outbreak will occur) predicted by this
model holds for nearly all epidemiological models, no matter
how elaborate: for each such model, one can derive an
appropriate expression involving the model’s parameters
such that the pathogen will persist only if this combination is
greater than one. For each speciﬁc model, such an analysis
gives us information on how one could eliminate the
pathogen within the context of the speciﬁc model. More
importantly, the fact that the threshold concept is ‘universal’,
appearing in nearly every model (an interesting exception
being the case of infection transmission models on ‘scale-
free’ networks [9]), makes us conﬁdent that it is not
dependent on very speciﬁc assumptions and should apply in
reality. We note, however, that we should be much less
conﬁdent about applying quantitative predictions obtained
from the SIR model to the real world. For example, although
an estimate for the vaccination coverage needed to prevent
the spread of a pathogen can be obtained from the SIR
model after estimating the parameters for this model from
available medical and epidemiological data, we would not
trust such a quantitative prediction unless it was conﬁrmed by
other more detailed models. Thus, even very simple models
such as the one described above provide some valid predic-
tions, but, in the case of such a simple model, one must
restrict the scope of the notion of prediction to refer to
certain key qualitative features that are robust. To obtain
quantitative predictions, we must make our models more
realistic, and hence more elaborate.
We next give some recent examples of some more
complex mathematical models that can be used to make
quantitative predictions in infectious disease epidemiology.
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Modelling vaccination
Vaccines are considered to constitute of the best preventive
measures to decrease the morbidity and mortality of infectious
diseases. Nonetheless, implementation of new vaccine policies
is a complex and challenging task for health authorities. Today,
modelling is a crucial element in any modern vaccination
programme, and should be used to evaluate different vaccina-
tion polices [10–16]. Predicting the overall vaccine effective-
ness is complicated and costly, and necessitates
population-based studies, which are frequently not feasible
[17]. Mathematical modelling is one of the only tools that
allows quantiﬁcation of the indirect protection provided by
immunization. Recently, two new vaccines, one targeted at
rotavirus, a leading cause of severe diarrhoea, and the other at
human papilloma virus (HPV), which is the cause of approx-
imately 5% of all human cancers [18], have been introduced.
Both vaccines have been implemented in many immunization
programmes in developed countries [11,15]. In order to
achieve a more complete epidemiological impact and to better
understand the effects of the vaccination, many transmission
models for both of these pathogens have been constructed
[10–16]. Here, we focus on the recently introduced HPV
vaccination programmes as an example of how models are
used to study and predict the outcome of vaccination
programmes. HPV raises many complex issues, as it involves
sexual transmission, adolescent vaccination, and signiﬁcant
differences between sexes in the expected outcomes. Over
the years, many models have been developed to study optimal
vaccination against HPV [10,11,19–25]. The models were used
to evaluate how variations in different biological processes,
such as immunity, partnership duration, virus strains, and
waning vaccine immunity, affect model predictions regarding
the effectiveness of vaccination policies [26]. In addition,
modelling provided insights into key questions such as the
target ages of optimal vaccination, and the relevant ‘catch-up’
policy.
A key issue where modelling has played a major part
regarding HPV vaccination policies is predicting the outcome
of including pre-adolescent males in future vaccination pro-
grammes [10,12,26]. On the one hand, themorbidity toll of HPV
is much higher in females; on the other hand, males play a
signiﬁcant role in virus transmission. The rationale of including
males is that an intervention aimed at both sexes adds to the
population-level impact (i.e. herd immunity) of targeting vacci-
nations at females only. Currently, more andmore countries are
considering the routine inclusion of males in national HPV
vaccination programmes [12,26]. Bogaards has demonstrated,
using both a simple model and more complex HPV transmission
model that also included a small group of males who have sex
with males, that the optimal strategy (for cases where vaccines
are limited or costly) inmost cases is to focus on the sexwith the
highest pre-vaccine incidence (female vaccination is preferred,
because the females often develop a persistent infection that
leads to an extended recovery rate relative tomales, i.e. a longer
period of infectiousness) [11]. In addition, the analysis outlines
the cases in which male vaccination should be reconsidered,
mainly if the rate of transmission from females to males is more
than twice as high as the rate of transmission from males to
females. The modellers stress that this outcome is independent
of many model assumptions and therefore robust, and “provide
a coherent argument in favor of increasing female vaccine
coverage as far as possible, given the limits set by vaccine
acceptance and economic constraints” [11].
The consistent outcome of other HPV modelling studies
was that vaccination of pre-adolescent females appears to be
the preferred policy, because they have a higher risk of
complication from infection (cervical cancers) and a prolonged
duration of infectiousness. In general, most models show that,
if moderate to high vaccine coverage of females is achieved
(approximately 70%), vaccination of males will have only
limited beneﬁts [10,19,20], and that efforts should be focused
on increasing female vaccine coverage.
Pandemic inﬂuenza
The emergence of a pandemic inﬂuenza strain is generally
considered to be inevitable [27,28]. At the global level, the
next pandemic may cause severe morbidity, mortality and
extensive economic impact in its wake. Current estimations of
the mortality from the 1918 pandemic are over 50 million
dead, making this pandemic the greatest natural disaster of
modern times [28]. Although, because of modern technologies
and medicine, future pandemics will probably have milder and
less severe outcomes than the 1918 pandemic, present with
present transportation systems infectious diseases are likely to
propagate much more quickly across the globe. For instance,
the 2009 H1N1 (‘swine ﬂu’) pandemic is now considered to
have been the fastest-moving pandemic in world history [29].
Modelling is a crucial element in any modern preparedness
programme, and can be used to improve our understanding of
the pathways and the dynamics of the spread of the pandemic
[30,31]. The Royal Society Committee [32] on infectious
diseases concluded that “Quantitative modeling is one of the
essential tools both for developing strategies in preparation for
an outbreak and for predicting and evaluating the effectiveness
of control policies during an outbreak … More work is
required to reﬁne the existing models and to strengthen their
capacity to inform policy.”
Health policy/decision-makers are faced with a wide range
of potential intervention policies regarding an inﬂuenza
pandemic. A key priority is to mitigate the pandemic until a
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vaccine for the speciﬁc virus is developed (estimated to take
approximately 6 months). One or more of the following
measures can be implemented [33–35]: antiviral prophylaxis,
quarantines, school closure, reduction in travel, and social
distancing. Mathematical models, using appropriate inputs,
which are expected to be part of ‘pandemic planning’, can help
to calculate the ‘optimal’ quantitative set of actions that will
reduce the impact of the pandemic to a minimum, in terms of
both public health and economic consequences. For instance, a
typical scenario might be one in which the availability of
pharmaceuticals (e.g. antiviral medication and vaccines) is
limited. Mathematical models can be used to investigate how,
when and to which sectors of the population the drugs should
be distributed in time [34]. As another example, it has been
shown that travel and/or border restrictions will have minor
beneﬁts (given the high social cost and therefore difﬁculty in
execution) in slowing the spread of a pandemic [36], and that
efforts should be focused at containing the pandemic at the
source.
In order to use mathematical models effectively for investi-
gating the dynamics of the spread of a pandemic, including
possible control strategies, there is a need to be conﬁdent that
the values used for the various parameters in the model
correspond to reality. Although some parameters can be
determined on the basis of previous knowledge, other param-
etersmust be estimated by ﬁtting themodel to the available data.
Thus, ﬁtting epidemiological models to real data becomes a
central problem during the ﬁrst phase of an outbreak [37,38].
The 2009 pandemic has demonstrated the importance of having
the capabilities to estimate parameters by developing and
adapting mathematical models and statistical methods well in
advance, so they can be easily implemented as early as possible to
estimate the disease-speciﬁc parameters. Acting as quickly as
possible and establishing rapid policy schemes is crucial.
However, in many cases, such urgent decisions may have to be
made under conditions of great uncertainty, owing to the lack, or
poor quality, of data [29,39]. For instance, during the 2009
pandemic, early estimates of key parameters such as R0 were
published at the ﬁrst stage of the outbreak (June 2009) [40], by
ﬁtting a simplemathematicalmodel that included two age groups
and age-dependent susceptibility to data from LaGloria, Mexico,
where the new H1N1 virus probably made its ﬁrst appearance.
As the estimates of R0 were similar to the lower values used in
previous modelling efforts that were used to develop pan-
demic-mitigation strategies [34,41], it was possible to use
previous results regarding the different control strategies [40] to
guide decision-making.
An important role of modelling in the study of an outbreak
is played by deviations between a ﬁtted model and the
observed data, as such differences can point to signiﬁcant
factors that were neglected by the model and need to be
accounted for. During the last pandemic in Israel, when the
observed incidence curves of different age groups were
compared with simulations of the same age group from a
model, certain deviations of the data from the model
predictions were noted in the young adult age group, and
were shown to be related to outbreaks among soldiers [38].
Such discrepancies need to be taken into consideration,
because they can have a signiﬁcant impact on the decision on
where to focus mitigation efforts.
During the 2009 pandemic, considerable differences in the
rates of spread of the pandemic among different geographical
locations were observed in the northern hemisphere. Differ-
ences were also observed in the timing of the outbreaks. In the
USA and UK, the pandemic had a ﬁrst wave in early summer,
but in continental Europe the pandemic started during the
autumn [1]. By the use of a complex individual-based stochastic
model that was parameterized with the data collected at the
ﬁrst stages of the outbreak in Mexico [40], it was possible to
study which elements were of most signiﬁcance for the
predictability of the spread of the pandemic in Europe. With
the model, it was possible to demonstrate that the ingredients
needed to provide predictions of the timing of the spread of
the disease in different countries in Europe were: (i) the
different transmission rates among different social groups; (ii)
population mobility patterns; and (iii) country-speciﬁc demog-
raphy. In recent years, progress has been made developing
massive models of the entire world population and global
transportation ﬂows, which are hoped to signiﬁcantly enhance
the capacity to make predictions regarding the spread of a
pandemic across the globe [42,43]. Future studies of outbreaks
(e.g. the SARS outbreak) should provide data that will enable
the performance of these models to be tested.
Conclusions
An important advantage of using models is that the mathe-
matical representation of biological processes enables trans-
parency and accuracy regarding the epidemiological
assumptions, thus enabling us to test our understanding of
the disease epidemiology by comparing model results and
observed patterns [44]. A model can also assist in deci-
sion-making by making projections regarding important issues
such as intervention-induced changes in the spread of disease.
A point that deserves emphasis is that transmission models are
based on the current understanding of the natural history of
infection and immunity. In cases where such knowledge is
lacking, assumptions can be made regarding these processes.
However, in such cases there can be several possible
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mechanisms, and therefore several different models, which can
lead to similar observed patterns, so that it is not always
possible to learn about underlying mechanisms by comparing
model outcomes. One must then be very cautious regarding
model predictions, because different models that lead to
similar outcomes in one context may fail to do so in another.
In such instances, it is best to conduct further epidemiological
and experimental studies in order to discriminate among the
different possible mechanisms. Thus, an important role of
modelling enterprises is that they can alert us to the
deﬁciencies in our current understanding of the epidemiology
of various infectious diseases, and suggest crucial questions for
investigation and data that need to be collected. Therefore,
when models fail to predict, this failure can provide us with
important clues for further research.
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